Funded Tech Companies
Reneo Pharmaceuticals
Wondering who provided funding to Reneo Pharmaceuticals? Lundbeckfond Ventures, Aisling Capital and New Enterprise Associates joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Reneo Pharmaceuticals
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
12230 El Camino Real 230
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. Many of these diseases are associated with deficits in cellular metabolism and energy production.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/9/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Flesher
Chief Medical Officer
Alejandro Dorenbaum
Chief Operating Officer
Wendy Johnson
VP - Operations
Lynn Purkins
Company Investors
- Lundbeckfond Ventures
- Aisling Capital
- New Enterprise Associates
- Rock Springs Capital
- Novo Nordisk Biotech Fund
- Abingworth
- Pappas Ventures
- RiverVest Venture Partners
- Amzak Health Investors
Browse more funded tech companies:
Renegade Brands | Renesas Electronics Corporation
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs